Stockreport

Anthem, HealthCore and Novo Nordisk Launch Large, Real-World Pragmatic Study to Understand the Effectiveness of a New Type 2 Diabetes Drug

Anthem, Inc.  (ANTM) 
Last anthem, inc. earnings: 4/29 06:00 am Check Earnings Report
US:NYSE Investor Relations: ir.antheminc.com
PDF Real-world study compares Ozempic® (semaglutide) to other standard diabetes therapies WILMINGTON, Del.--(BUSINESS WIRE)-- HealthCore, Inc., th [Read more]